Collector
Generic drugmaker Apotex switches CEO ahead of planned IPO | Collector
Generic drugmaker Apotex switches CEO ahead of planned IPO
Globe Money

Generic drugmaker Apotex switches CEO ahead of planned IPO

Jeff Watson, who led Apotex from 2018 to 2023, will replace Allan Oberman, who is departing from the role

Go to News Site